This information is for reference purposes only. It was current when produced and may now be outdated. Archive material is no longer maintained, and some links may not work. Persons with disabilities having difficulty accessing this information should contact us at: https://info.ahrq.gov. Let us know the nature of the problem, the Web address of what you want, and your contact information.
On April 3, 2009, public testimony on comparative effectiveness research was given at a meeting of the National Advisory Council for Healthcare Research and Quality. The testimony represents the views of the presenter and not necessarily those of the Agency for Healthcare Research and Quality (AHRQ) or the Department of Health and Human Services (HHS).
For the estimated 70 million Americans with hypertension and the tens of millions more at risk, how would government regulations lowering sodium content in restaurant and processed foods compare to usual treatment (relying on the health care delivery system to diagnose and treat) to reduce hypertension and the resulting cardiovascular disease in the overall population.
Page last reviewed April 2009
Internet Citation: Testimony on Comparative Effectiveness Research: Center for Science in the Public Interest.
April 2009. Agency for Healthcare Research and Quality, Rockville, MD. https://archive.ahrq.gov/news/speech/cpsi_tnf.html
The information on this page is archived and provided for reference purposes only.